Navigation Links
FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
Date:1/8/2014

VICTOR, N.Y., Jan. 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief—custom transdermal creams for pain and inflammation—today announced the appointment of Douglas B. Slomski to the position of Vice President of Sales and Marketing.  Effective immediately, Slomski will be responsible for expanding the company's presence in existing markets, as well as opening new markets and launching products. The company also announced today that the Cleveland Clinic study for the treatment of knee pain using Diclofenac Cream 8% or 1% has moved to the next phase, with participant enrollment to begin in the first quarter of 2014.

Slomski brings to FPR Specialty Pharmacy a 25-year background in marketing life-science products and extensive expertise in medical sales management. He most recently served on the management team at ECA Medical Instruments, where he helped with the global unveiling of a line of surgical kitting products and oversaw a five-year branding and implementation program.  Known for his solutions-based approach, Slomski is a global expert at growing revenue and market share through end-to-end product management and targeted sales strategies. He is also credited with over 12 patents in medical devices, packaging and sterilization processing equipment.

"FPR Specialty Pharmacy has exciting and aggressive plans to move the company forward in 2014. Doug Slomski is a top talent in the industry and his knowledge will further strengthen our management team and our position to achieve our goals," said Billy Rue, CEO of FPR Specialty Pharmacy.

As part of its expansion efforts, FPR Specialty Pharmacy is engaging in the Cleveland Clinic study to measure the effectiveness of Diclofenac creams in treating knee pain.  This research will provide valuable insights for treating pain and inflammation in the knee.  "This is a hallmark study for our industry and we greatly value partnering with the Cleveland Clinic on this project," said Rue. 

ABOUT FPR SPECIALTY PHARMACY
FPR Specialty Pharmacy is an advanced traditional compounding pharmacy specializing in solutions for relief of pain and inflammation.  The company's leading product, Focused Pain Relief, is a custom compounded, prescription-based transdermal cream. FPR Specialty Pharmacy is located in Victor, New York.  Learn more at: www.focusedpainrelief.com or follow FPR Specialty Pharmacy on LinkedIn.


'/>"/>
SOURCE FPR Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Numotion Acquires Specialty Wheelchairs, LLC
2. Endo to Acquire Specialty Pharmaceutical Company NuPathe
3. New Physicians Survey: Most Drugstores Lack the Expertise and Capability to Provide Specialty Medications
4. Giant Eagle Expands Specialty Pharmacy with Acquisition, Bringing Treatment Expertise to Customers with Hepatitis C and Organ Transplant Conditions
5. Tampa Pharmacist Receives Specialty Pharmacy Certification Credential from SPCB
6. Centene Specialty Pharma Subsidiary Receives Full URAC Accreditation
7. CVS Caremark to Purchase Coram Infusion Business from Apria Healthcare, Expanding Specialty Pharmacy Offering
8. Student Residency Program Planned by the National Association of Specialty Pharmacy (NASP)
9. Global Markets For Specialty Surgical Wound Care Products In 2013: Surgical Sealants, Glues, Absorbable Hemostats, And Adhesion Prevention Products
10. Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
11. Pan Foundation Convenes Dialogue Series On Issues Surrounding Access To Specialty Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):